Ochsner Medical Center - Baton Rouge has earned The Joint Commission’s Gold Seal of Approval and the American Stroke Association’s Heart-Check mark for Acute Stroke Ready Certification
May 20, 2024
Ochsner Medical Center-Baton Rouge earns Acute Stroke Ready Certification from Joint Commission
May 20, 2024 — Ochsner Medical Center - Baton Rouge has earned The Joint Commission’s Gold Seal of Approval and the…
Read More
Cardiologist Brendan Carry, MD, and a team of Geisinger Medical Center physicians have enrolled the first patient in the U.S. into a cardiac amyloidosis trial. Image courtesy: Geisinger Medical Center/Mark Dastrup
May 20, 2024
Geisinger Enrolls First Patient in Amyloid Cardiomyopathy Trial
May 20, 2024 — Cardiologist Brendan Carry, MD, and a team of Danville, PA-based Geisinger Medical Center physicians…
Read More
Early Cardiac Resynchronization Therapy (CRT) may slow the progression of heart failure in patients with mild to moderately reduced left ventricular ejection fraction (LVEF) and left bundle branch block (LBBB), according to a study conducted by a research team led by Yong-Mei Cha, MD, cardiac electrophysiologist at Mayo Clinic, Rochester, MN, presented during the Heart Rhythm Society meeting, HRS 2024.
May 18, 2024
Clinical Trial Presented at HRS 2024 Shows Benefits of Early Cardiac Resynchronization Therapy (CRT) in Slowing Progression of Heart Failure
May 19, 2024 — A physician-initiated prospective, randomized clinical trial sponsored by the National Heart, Lung, and…
Read More
Additional data from APPRAISE ATP trial reinforce modular therapy approach with EMBLEM Subcutaneous Implantable Defibrillator and EMPOWER Leadless Pacemaker
May 18, 2024
MODULAR ATP Study of the mCRM System Meets Primary Safety and Efficacy Endpoints
May 18, 2024 — Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal…
Read More
During the Heart Rhythm Society (HRS) annual meeting, HRS 2024, findings from three new studies demonstrating the safety and efficacy of pulsed field ablation (PFA), for patients with atrial fibrillation (AF) were presented. Learn more of the late-breaking science from the FARADISE, admIRE Study, and Advent Trial here.
May 18, 2024
Late-breaking Clinical Trial Results from FARADISE, admIRE Study and Advent Trial at Heart Rhythm 2024 Highlight Pulsed Field Ablation Developments for Atrial Fibrillation Treatment
May 18, 2024 — The Heart Rhythm Society (HRS) has announced the findings of three new studies demonstrating the safety…
Read More
Three studies demonstrate how Philips MCOT wearable ambulatory monitoring ECG and proprietary AI models applied to ECG digital biomarkers can help to improve diagnosis, reduce readmissions, and lower costs
May 17, 2024
Philips Presents Study Results at Heart Rhythm Annual Meeting Demonstrating Benefits of its AI-powered Cardiac Monitoring Solutions
May 17, 2024 — Royal Philips, a global leader in health technology, is presenting new retrospective study results…
Read More
Baseline characteristics from FINE-HEART analysis highlight complex interplay between cardiovascular, kidney, and metabolic health, with over 92% of patients presenting two or more conditions
May 17, 2024
Study Design and Baseline Characteristics of Prespecified, Exploratory Pooled Analysis to Investigate Effect of Finerenone on Cardio-Kidney Outcomes in Patients with CKD and Type 2 Diabetes/Heart Failure
May 17, 2024 — The study design and baseline characteristics of FINE-HEART, a new prespecified, exploratory pooled…
Read More
Cutting-edge tool analyzes data from cardiac remote monitoring devices to assess whether a patient is at high risk of experiencing worsening heart failure, enabling medical teams to intervene and avoid hospitalization.
May 17, 2024
Implicity Earns FDA Clearance for New Heart Failure Prediction Algorithm
May 17, 2024 —  Implicity, a leader in remote patient monitoring and cardiac data management solutions, announced it…
Read More
NIH-funded study suggests addressing these factors could reduce health disparities
May 16, 2024
Adverse Social Determinants of Health Linked to Treatment-resistant Hypertension in Black Americans
May 16, 2024 — People were more likely to develop a type of treatment-resistant hypertension when they experienced…
Read More
A recent publication in the American Heart Association Circulation highlights a comprehensive investigation to assess the impact of revascularization strategies on the health-related quality of life (HRQoL) of patients suffering from chronic limb-threatening ischemia
May 16, 2024
Improving Life Quality in Chronic Limb-Threatening Ischemia Through Revascularization
May 16, 2024 — A recent publication in the American Heart Association Circulation highlights a comprehensive…
Read More
Researcher presents findings at European Stroke Organization Conference
May 16, 2024
University of Cincinnati Study Finds Severe Ischemic Strokes are Rare in Patient Population
May 16, 2024 — A new University of Cincinnati study provides more insight into how few patients have severe ischemic…
Read More
A new joint guideline from the American Heart Association (AHA), the American College of Cardiology (ACC) and nine other medical societies reports early diagnosis and treatment of peripheral artery disease is essential to improve outcomes and reduce amputation risk, heart attack, stroke and death for people with Peripheral Artery Disease (PAD).
May 16, 2024
New Guidelines on Peripheral Artery Disease Issued by American Heart Association, American College of Cardiology and Leading Medical Societies
May 16, 2024 — Timely diagnosis and proper management of peripheral artery disease (PAD), including coordinated care…
Read More
A new study demonstrated parity between a minimally invasive procedure to replace the aortic valve in the heart
May 15, 2024
Transcatheter Valve Replacement Outcomes Similar to Surgery in Long-Term Analysis
May 15, 2024 — A new study demonstrated parity between a minimally invasive procedure to replace the aortic valve in…
Read More
CardioFocus will feature its portfolio of innovative ablation systems which optimize lesion creation via confirmed tissue contact and sophisticated energy delivery
May 15, 2024
CardioFocus to Present Data Supporting Next Generation Pulsed Field Ablation Systems at Heart Rhythm 2024
May 15, 2024 —CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for cardiac…
Read More
You can do a side-by-side comparison of some of the leading cardiovascular information systems by viewing DAIC’s newly updated CVIS Comparison Chart
By Melinda Taschetta-Millane
May 15, 2024
Trends Shaping the Cardiovascular Information Systems Market
In the dynamic realm of healthcare technology, cardiovascular information systems (CVIS) stand at the forefront,…
Read More
Abbott recalls HeartMate 3 left ventricular assist system (LVAS) implant kit for risk of blood leakage or air entering system between inflow cannula and apical cuff
May 15, 2024
FDA Announces Abbott Recall of HeartMate 3 Left Ventricular Assist System (LVAS) Implant Kit
May 15, 2024 — The U.S. Food and Drug Administration (FDA) announced that Abbott is recalling the HeartMate 3 LVAS by…
Read More
Lahey Health Medical Center Investigator Leads Phase 3 trial demonstrating novel therapy enhances exercise capacity, improves symptoms in patients obstructive HCM
May 14, 2024
New Treatment in Pipeline for Patients with Hypertrophic Cardiomyopathy
May 14, 2024 — One of the most common genetic heart diseases worldwide, hypertrophic cardiomyopathy (HCM) causes the…
Read More
Lahey Health Medical Center Investigator Leads Phase 3 trial demonstrating novel therapy enhances exercise capacity, improves symptoms in patients obstructive HCM
May 14, 2024
SHINE Trial Sheds Light on Deadly Stroke Complication
May 14, 2024 — An ambitious, nationwide clinical trial led by UVA Health’s Karen Johnston, MD, has provided doctors…
Read More
Collaboration seeks to advance precision care by providing an alternative, non-invasive approach to the assessment of coronary physiology
May 14, 2024
GE HealthCare and Medis Medical Imaging Announce Collaboration Focused on Non-Invasive Coronary Assessments to Help Advance Precision Care in Treatment of Coronary Artery Disease
May 14, 2024 — GE HealthCare, a leading global medical technology, pharmaceutical diagnostics and digital solutions…
Read More
STEP-HFpEF analysis presented in a late breaking science session today at Heart Failure 2024
May 13, 2024
Weight Loss Drug Linked with Reduced Need for Diuretics in Heart Failure Patients
May 13, 2024 — Semaglutide reduces the need for loop diuretic use and dose, and has positive effects on symptoms,…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now